IMR Press / RCM / Volume 14 / Issue 2-4 / DOI: 10.3909/ricm0693

Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.

Open Access Review
Cardiometabolic Risk Factors and Atrial Fibrillation
Show Less
1 Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA
2 Department of Preventative Cardiology, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA
3 Wegmans Pharmacy, Ithaca, NY
4 St. Luke's Mid America Heart Institute, Kansas City, MO
5 St. Luke's-Roosevelt Hospital Center, New York, NY
Rev. Cardiovasc. Med. 2013, 14(2-4), 73–81; https://doi.org/10.3909/ricm0693
Published: 30 June 2013
Abstract
Atrial fibrillation (AF) is the most common arrhythmia worldwide; it is a significant risk factor for stroke and embolization, and has an impact on cardiac function. Despite its impact on morbidity and mortality, our understanding of the etiology and pathophysiology of this disease process is still incomplete. Over the past several decades, there has been evidence to suggest that AF has a significant correlation with metabolic syndrome (MetS). Furthermore, AF appears to be more closely related to specific components of MetS compared with others. This article provides an overview of the various components of MetS and their impact on AF.
Keywords
Atrial fibrillation
Metabolic syndrome
Obesity
Hypertension
Diabetes
Share
Back to top